Delivery Order SPE2DB22D2206-SPE2DB25FFV76

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,737.60, is a Delivery Order for the supply of 4567387836 ! HYDROMORPHONE 500 MG/50 ML VL 50ML. The contract has an ultimate completion date of February 27, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,185.08 Firm Fixed Price Delivery Order contract is for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has an ultimate completion date of January 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of hydromorphone hydrochloride extended-release tablets, 32 mg, a pain management medication. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $2,692.00 and a period of performance through November 18, 2024. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.24, is for the delivery of Hydromorphone HCL ER Tablets 12mg. This is a firm fixed-price delivery order contract with an ultimate completion date of January 22, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,597.00 Firm Fixed Price Delivery Order is for the supply of Hydromorphone 2 mg/ml vials. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This federal contract award, valued at $1,504.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,248.83, is for the supply of hydromorphone 2 mg/ml in cartridges. The contract is a firm fixed-price delivery order with a completion date of September 10, 2024. Amerisourcebergen, through its Corporate Office Division, has been a significant supplier of pharmaceutical products and medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,137.70, is for the supply of hydromorphone 1 mg/ml carpujctml. This contract does not have a set-aside designation, indicating it was competitively awarded. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,711.56, is for the delivery of 4566355165 Hydromorphone HCL ER 8 mg tablets in 100-count bottles. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,603.00 Firm Fixed Price Delivery Order is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The award appears to be under a larger Indefinite Delivery Contract (IDC) vehicle that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFV76
    Delivery Order

This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.20 firm fixed-price delivery order is for HYDROMORPHONE 500 MG/50 ML VL 50ML, a pharmaceutical product. The contract has a completion date of February 27, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that broader IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/28/25, 11:05 AM